Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Welch

Showing results (611-620 of 740) with videos related to

Pageof 74
Sort By:
Future Oncology (London, England)|January 4, 2017
Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancerMark D Vincent, Daniel Breadner, Denis Soulieres, et al.
Translational Behavioral Medicine|August 16, 2021
User-centered development of a smartphone application (Fit2Thrive) to promote physical activity in breast cancer survivorsWhitney A Welch, Payton Solk, Lisa Auster-Gussman, et al.
Age and Ageing|October 26, 2025
Campbell and Cochrane evidence on promoting cognitive capacity across life course: a mapping reviewVivian A Welch, Monserrat Conde, Victoria I Barbeau, et al.
European Journal of Clinical Nutrition|January 11, 2000
Standardization of the 24-hour diet recall calibration method used in the european prospective investigation into cancer and nutrition (EPIC): general concepts and preliminary resultsN Slimani, P Ferrari, M Ocké, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 15, 2010
Orbitofrontal morphology in people at high risk of developing schizophreniaG Chakirova, K A Welch, T W J Moorhead, et al.
The Journal of ECT|June 4, 2016
Common Use of Electroconvulsive Therapy for Chinese Adolescent Psychiatric PatientsQing-E Zhang, Zhi-Min Wang, Sha Sha, et al.
Gynecologic Oncology|September 2, 2022
Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinomaAinhoa Madariaga, Sandra A Mitchell, Tyler Pittman, et al.
Circulation Research|April 5, 2017
Methodological Rigor in Preclinical Cardiovascular Studies: Targets to Enhance Reproducibility and Promote Research TranslationF Daniel Ramirez, Pouya Motazedian, Richard G Jung, et al.
Exploration of Targeted Anti-Tumor Therapy|October 1, 2024
Evaluation of HER2 immunohistochemistry expression in non-standard solid tumors from a Single-Institution Prospective CohortSaurav Verma, Amanda Chapman, Lee-Anne Pickard, et al.
BMJ Open|September 19, 2022
Research priority setting related to older adults: a scoping review to inform the Cochrane-Campbell Global Ageing Partnership work programmeVictoria I Barbeau, Leen Madani, Abdulah Al Ameer, et al.
Pageof 74

Showing results (611-620 of 740) with videos related to

Sort By:
Pageof 74
Future Oncology (London, England)|January 4, 2017
Phase II trial of capecitabine plus erlotinib versus capecitabine alone in patients with advanced colorectal cancerMark D Vincent, Daniel Breadner, Denis Soulieres, et al.
Translational Behavioral Medicine|August 16, 2021
User-centered development of a smartphone application (Fit2Thrive) to promote physical activity in breast cancer survivorsWhitney A Welch, Payton Solk, Lisa Auster-Gussman, et al.
Age and Ageing|October 26, 2025
Campbell and Cochrane evidence on promoting cognitive capacity across life course: a mapping reviewVivian A Welch, Monserrat Conde, Victoria I Barbeau, et al.
European Journal of Clinical Nutrition|January 11, 2000
Standardization of the 24-hour diet recall calibration method used in the european prospective investigation into cancer and nutrition (EPIC): general concepts and preliminary resultsN Slimani, P Ferrari, M Ocké, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 15, 2010
Orbitofrontal morphology in people at high risk of developing schizophreniaG Chakirova, K A Welch, T W J Moorhead, et al.
The Journal of ECT|June 4, 2016
Common Use of Electroconvulsive Therapy for Chinese Adolescent Psychiatric PatientsQing-E Zhang, Zhi-Min Wang, Sha Sha, et al.
Gynecologic Oncology|September 2, 2022
Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinomaAinhoa Madariaga, Sandra A Mitchell, Tyler Pittman, et al.
Circulation Research|April 5, 2017
Methodological Rigor in Preclinical Cardiovascular Studies: Targets to Enhance Reproducibility and Promote Research TranslationF Daniel Ramirez, Pouya Motazedian, Richard G Jung, et al.
Exploration of Targeted Anti-Tumor Therapy|October 1, 2024
Evaluation of HER2 immunohistochemistry expression in non-standard solid tumors from a Single-Institution Prospective CohortSaurav Verma, Amanda Chapman, Lee-Anne Pickard, et al.
BMJ Open|September 19, 2022
Research priority setting related to older adults: a scoping review to inform the Cochrane-Campbell Global Ageing Partnership work programmeVictoria I Barbeau, Leen Madani, Abdulah Al Ameer, et al.
Pageof 74